RxSight (RXST) EBT Margin (2020 - 2026)
RxSight's (RXST) quarterly EBT Margin came in at 35.59% in Q2 2026, down 65.0% on a YoY basis from 101.69% in Q2 2025, and up 30.75% quarter-over-quarter from 51.4% in Q1 2026.
Powered by 
Analysis
RxSight (RXST) EBT Margin (2020 - 2026) Analysis & Trends
RxSight (RXST) has reported EBT Margin for 7 consecutive years, with 35.59% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EBT Margin fell 65.0% year-over-year to 35.59%; the trailing twelve-month figure through Jun 2026 stood at 36.71% (down 1483.0% YoY), and the FY2025 full-year result was 28.91%, down 932.0% from the prior year.
- EBT Margin advanced to 35.59% in Q2 2026 per RXST's latest filing, from 51.4% in the prior quarter.
- Across five years, EBT Margin topped out at 14.74% in Q4 2024 and bottomed at 196.73% in Q1 2022.
- Historically, EBT Margin has averaged 60.49% across 5 years, with a median of 35.27% in 2025.
- The sharpest annual moves came in 2022 and 2026: EBT Margin surged 12786 bps in 2022, then sank 2983 bps in 2026.
- Over 5 years, EBT Margin stood at 97.02% in 2022, then jumped by 67 bps to 32.18% in 2023, then surged by 54 bps to 14.74% in 2024, then slumped by 90 bps to 28.05% in 2025, then slipped by 27 bps to 35.59% in 2026.
- According to Business Quant data, EBT Margin over the past three periods registered 35.59%, 51.4%, and 28.05% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | 12.10% |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 36.46% |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 18.13% |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 23.74% |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 19.48% |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 29.86% |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | -1.65% |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 24.27% |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | 18.32% |
| 10 | RxSight | 265.31 Mn | -138.93 Mn | - | -35.59% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -35.59% |
| Mar 31, 2026 | -51.40% |
| Dec 31, 2025 | -28.05% |
| Sep 30, 2025 | -32.32% |
| Jun 30, 2025 | -34.94% |
| Mar 31, 2025 | -21.56% |
| Dec 31, 2024 | -14.74% |
| Sep 30, 2024 | -17.91% |
| Jun 30, 2024 | -17.38% |
| Mar 31, 2024 | -30.80% |
| Dec 31, 2023 | -32.18% |
| Sep 30, 2023 | -55.87% |
| Jun 30, 2023 | -66.21% |
| Mar 31, 2023 | -75.54% |
| Dec 31, 2022 | -97.02% |
| Sep 30, 2022 | -133.32% |
| Jun 30, 2022 | -147.29% |
| Mar 31, 2022 | -196.73% |
| Dec 31, 2021 | -186.87% |
| Sep 30, 2021 | -219.10% |